TRANSPLANTATION AND CELLULAR THERAPY CERTIFIED NURSE Trademark
Trademark Overview
On Wednesday, October 30, 2024, a trademark application was filed for TRANSPLANTATION AND CELLULAR THERAPY CERTIFIED NURSE with the United States Patent and Trademark Office. The USPTO has given the TRANSPLANTATION AND CELLULAR THERAPY CERTIFIED NURSE trademark a serial number of 98828279. The federal status of this trademark filing is NEW APPLICATION - RECORD INITIALIZED NOT ASSIGNED TO EXAMINER as of Wednesday, October 30, 2024. This trademark is owned by Oncology Nursing Certification Corporation. The TRANSPLANTATION AND CELLULAR THERAPY CERTIFIED NURSE trademark is filed in the category with the following description:
Oncology nursing services event
General Information
Serial Number | 98828279 |
Word Mark | TRANSPLANTATION AND CELLULAR THERAPY CERTIFIED NURSE |
Filing Date | Wednesday, October 30, 2024 |
Status | 630 - NEW APPLICATION - RECORD INITIALIZED NOT ASSIGNED TO EXAMINER |
Status Date | Wednesday, October 30, 2024 |
Registration Number | 0000000 |
Registration Date | NOT AVAILABLE |
Mark Drawing | 4 - Illustration: Drawing with word(s) / letter(s) / number(s) in Block form |
Published for Opposition Date | NOT AVAILABLE |
Trademark Statements
Goods and Services | Oncology nursing services event |
Certification Mark Statement | The certification mark, as used by authorized persons, certifies that persons performing oncology nursing services have met the standards, qualifications, and testing requirements established by the Certifier |
Classification Information
International Class | B - |
US Class Codes | B |
Class Status Code | 6 - Active |
Class Status Date | Wednesday, October 30, 2024 |
Primary Code | B |
First Use Anywhere Date | NOT AVAILABLE |
First Use In Commerce Date | NOT AVAILABLE |
Trademark Owner History
Party Name | Oncology Nursing Certification Corporation |
Party Type | 10 - Original Applicant |
Legal Entity Type | 99 - Other |
Address | Pittsburgh, PA 15275 |
Trademark Events
Event Date | Event Description |
Wednesday, October 30, 2024 | NEW APPLICATION ENTERED |